Literature DB >> 11489138

Cases of Alzheimer's disease due to deletion of exon 9 of the presenilin-1 gene show an unusual but characteristic beta-amyloid pathology known as 'cotton wool' plaques.

D M Mann1, A Takeuchi, S Sato, N J Cairns, P L Lantos, M N Rossor, M Haltia, H Kalimo, T Iwatsubo.   

Abstract

The pattern of deposition of amyloid beta protein (Abeta) was investigated, using the monoclonal antibodies BA27 and BC05 detecting the C-terminal species Abeta40 and Abeta42(43), in six cases of Alzheimer's disease (AD) due to deletions in exon 9 of PS-1 gene. These cases are characterized histologically by the presence of very large rounded plaques within the frontal cortex, known as 'cotton wool' plaques, composed of both Abeta40 and Abeta42(43) that are relatively free from neuritic changes and glial cell components, and usually devoid of a compact amyloid core. In the cerebellum the plaques are almost entirely of a compact type, again composed of Abeta40 and Abeta42(43), with only few diffuse Abeta42(43) containing plaques. The area fraction of Abeta40, and the ratio between Abeta40 and Abeta42(43), in frontal cortex was significantly higher than that seen in other cases of AD due to different PS-1 mutations, or in cases of sporadic AD, all of similar APO E genotype. The area fractions of Abeta42(43), however, did not significantly differ between these three groups. The unusual nature of the Abeta deposition in these cases may reflect the uniqueness of the mutation, which results in a failure to constitutively cleave the PS-1 holoprotein into its active form, and the effect this might have on APP trafficking and catabolism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11489138     DOI: 10.1046/j.1365-2990.2001.00316.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  10 in total

1.  Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease.

Authors:  D M Mann; S M Pickering-Brown; A Takeuchi; T Iwatsubo
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

2.  Presenilin1 G217R mutation linked to Alzheimer disease with cotton wool plaques.

Authors:  J B Norton; N J Cairns; S Chakraverty; J Wang; D Levitch; J E Galvin; A Goate
Journal:  Neurology       Date:  2009-08-11       Impact factor: 9.910

3.  Heparan sulfate accumulation with Abeta deposits in Alzheimer's disease and Tg2576 mice is contributed by glial cells.

Authors:  Paul O'Callaghan; Elina Sandwall; Jin-Ping Li; Hong Yu; Rivka Ravid; Zhi-Zhong Guan; Toin H van Kuppevelt; Lars N G Nilsson; Martin Ingelsson; Bradley T Hyman; Hannu Kalimo; Ulf Lindahl; Lars Lannfelt; Xiao Zhang
Journal:  Brain Pathol       Date:  2008-04-11       Impact factor: 6.508

4.  Presenilin/gamma-Secretase and Inflammation.

Authors:  Carlos A Saura
Journal:  Front Aging Neurosci       Date:  2010-05-18       Impact factor: 5.750

5.  Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's disease.

Authors:  Sara E Dodson; Olav M Andersen; Vinit Karmali; Jason J Fritz; Dongmei Cheng; Junmin Peng; Allan I Levey; Thomas E Willnow; James J Lah
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

6.  Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study.

Authors:  Jasmeer P Chhatwal; Stephanie A Schultz; Eric McDade; Aaron P Schultz; Lei Liu; Bernard J Hanseeuw; Nelly Joseph-Mathurin; Rebecca Feldman; Colleen D Fitzpatrick; Kathryn P Sparks; Johannes Levin; Sarah B Berman; Alan E Renton; Bianca T Esposito; Maria Vitoria Fernandez; Yun Ju Sung; Jae Hong Lee; William E Klunk; Anna Hofmann; James M Noble; Neill Graff-Radford; Hiroshi Mori; Steven M Salloway; Colin L Masters; Ralph Martins; Celeste M Karch; Chengjie Xiong; Carlos Cruchaga; Richard J Perrin; Brian A Gordon; Tammie L S Benzinger; Nick C Fox; Peter R Schofield; Anne M Fagan; Alison M Goate; John C Morris; Randall J Bateman; Keith A Johnson; Reisa A Sperling
Journal:  Lancet Neurol       Date:  2022-02       Impact factor: 44.182

Review 7.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

Review 8.  Reactive astrocytes as treatment targets in Alzheimer's disease-Systematic review of studies using the APPswePS1dE9 mouse model.

Authors:  Tamar Smit; Natasja A C Deshayes; David R Borchelt; Willem Kamphuis; Jinte Middeldorp; Elly M Hol
Journal:  Glia       Date:  2021-02-25       Impact factor: 7.452

9.  Variability in the type and layer distribution of cortical Aβ pathology in familial Alzheimer's disease.

Authors:  Nanet Willumsen; Teresa Poole; Jennifer M Nicholas; Nick C Fox; Natalie S Ryan; Tammaryn Lashley
Journal:  Brain Pathol       Date:  2021-07-28       Impact factor: 7.611

10.  Patterns and severity of vascular amyloid in Alzheimer's disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer's disease.

Authors:  David M A Mann; Yvonne S Davidson; Andrew C Robinson; Nancy Allen; Tadafumi Hashimoto; Anna Richardson; Matthew Jones; Julie S Snowden; Neil Pendleton; Marie-Claude Potier; Annie Laquerrière; Vee Prasher; Takeshi Iwatsubo; Andre Strydom
Journal:  Acta Neuropathol       Date:  2018-05-16       Impact factor: 17.088

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.